Gene Query: KCMF1

Dataset Description Geneva Score
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 41.1
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 33.85
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 30.0
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 23.63
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 20.49
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 20.49
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 20.15
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 20.11
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 20.11
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 18.8
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 18.34
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 17.44
The comparison of high-throughput single-cell RNA-seq methods 16.67
MYCi361 regulates MYC target genes 16.36
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 15.74
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 15.66
Identifying the molecular mode of action of itraconazole in colorectal cancer 15.54
Tracking of dCas9-methyltransferase footprints 15.46
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 15.15
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 14.78
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 14.49
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 14.29
Effect of mitochondria deficiency on senescence-associated gene expression 14.12
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 13.78
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 13.71
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 13.68
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 13.68
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 12.96
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 12.57
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 12.47
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 12.36
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 12.36
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 12.35
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 12.27
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 11.98
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 11.82
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 11.82
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 11.73
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 11.6
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 11.56
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 11.42
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 11.37
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 11.37
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 11.36
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 11.32
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 11.23
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 11.21
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 11.17
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 11.14
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 10.9
RNA-Seq from early time points in the kidney differentiation protocol 10.74
Cleavage Factor Im as a key regulator of 3’ UTR length 10.72
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 10.71
MARS Seq data from human cortical organoids 10.68
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 10.61
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 10.48
SLAM-seq for K562 endogenous mRNA decay 10.29
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 10.24
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 10.24
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 10.2
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 10.19
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 10.01
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 9.96
RNA sequencing of GlyH-101-treated MCF-7 cell line 9.7
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 9.46
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 9.41
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 9.17
A sister of NANOG regulates genes expressed in pre-implantation human development 9.14
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 9.07
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 9.06
RNA-seq analyses of human prostate cancer cells 8.99
NKX2.2 8.87
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 8.87
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 8.83
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 8.78
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 8.61
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 8.56
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 8.55
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 8.53
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 8.47
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 8.44
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 8.37
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 8.28
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 8.24
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 8.1
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 8.1
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 8.08
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 8.08
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 8.04
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 8.03
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 8.03
Neonatal and adult human testis defined at the single-cell level 8.02
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 8.01
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 7.98
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 7.98
IRF1 regulates IFN dependent and independent gene expression 7.87
RNA-seq of Single-Cell Genotyping of Transcriptomes 7.83
Single-Cell Genotyping of Transcriptomes 7.83
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 7.74
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 7.74
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 7.71
Hepatitis C virus functionally sequesters miR-122 7.71
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 7.7
Depicting early human development and germ cell origin with porcine embryos 7.69
SLIGRL-induced gene expression changes in NHEK cells 7.62
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 7.61
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 7.61
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 7.58
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 7.55
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 7.54
Global expression profiles in cardiac progenitor cells generated by ISX-9 7.54
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 7.51
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 7.5
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 7.49
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 7.41
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 7.33
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 7.31
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 7.3
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 7.3
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 7.24
Transcriptome analysis in Neobractatin treated cells 7.23
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 7.19
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 7.17
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 7.08
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 7.05
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 7.02
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 7.02
MYCi975 regulates MYC target genes 7.01
SETBP1-WT and SETBP1-G870S epigenetic landscapes 6.97
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 6.97
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 6.97
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 6.85
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 6.84
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 6.83
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 6.81
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 6.81
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 6.81
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 6.81
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 6.75
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 6.75
A prostate cancer chromatin interaction map 6.75
CDK12 mediated transcriptional regulation in U2OS cells 6.75
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 6.74
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 6.74
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 6.64
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 6.61
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 6.57
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 6.56
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 6.55
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 6.55
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 6.55
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 6.52
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 6.46
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 6.39
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 6.39
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 6.36
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 6.36
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 6.33
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 6.33
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 6.29
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 6.29
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 6.29
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 6.27
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 6.25
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 6.25
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 6.17
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 6.16
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 6.15
CD95/Fas ligand mRNA is toxic to cells 6.14
Active translatome profiling with RiboLace in MCF7 cells 6.13
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 6.12
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 6.07
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 6.06
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 6.06
Crizotinib v. DMSO in SW480 cells 6.05
The interplay between SOX4 and SMAD3 in the context of breast cancer 6.01
High-throughput sequencing of pluripotent cells 5.99
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 5.98
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 5.97
Seletive inhibition of CDK9 in DLBCL cell lines 5.93
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 5.92
HEXIM1 is induced by DHODH inhibition to suppress melanoma 5.92
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 5.91
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 5.91
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 5.89
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 5.86
Solid phase chemistry to covalently and reversibly capture thiolated RNA 5.85
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 5.83
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 5.83
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 5.83
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 5.81
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 5.75
Differentially expressed vascular development genes for iPSC-ECs from CDI 5.74
RNAseq of HEK293 cells after Chtop knockdown 5.73
Co-transcriptional loading of RNA export factors shapes the human transcriptome 5.73
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 5.73
RNA-Seq with and without RNase treatment in PCa cell lines 5.73
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 5.71
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 5.68
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 5.66
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 5.65
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 5.65
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 5.65
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 5.65
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 5.65
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 5.63
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 5.63
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 5.62
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 5.62
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 5.61
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 5.61
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 5.59
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 5.59
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 5.59
RNA-seq analysis of RALD iPSCs after in vitro differentiation 5.57
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 5.55
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 5.55
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 5.55
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 5.52
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 5.51
U1 snRNP telescripting regulates size-function stratified human genome 5.51
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.47
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 5.46
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 5.46
NHLRC1 re-expression in cancer cells 5.45
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 5.45
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 5.45
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 5.45
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 5.45
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 5.43
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 5.43
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 5.37
Electronic cigarettes 5.36
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 5.35
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 5.34
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 5.25
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 5.25
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 5.22
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 5.22
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 5.2
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 5.2
R430: A potent inbibitor of DNA and RNA viruses 5.14
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 5.12
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 5.1
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 5.09
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 5.09
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 5.09
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 5.07
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 5.07
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 5.06
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 5.05
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 5.05
Illumina Total RNA-seq in HeLa 5.04
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 5.02
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 5.0
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 5.0
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 4.97
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 4.97
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.96
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 4.95
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 4.9
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 4.86
Searching for target genes of miR-508/509/506/514 in HCT116 cells 4.67
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 4.65
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 4.59
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 4.59
Noncoding regions are the main source of targetable tumor-specific antigens 4.57
Human HAP1 cells before and after nutrient deprivation 4.56
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 4.56
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 4.54
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.54
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 4.51
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 4.49
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 4.47
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 4.47
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 4.45
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.44
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 4.44
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 4.44
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 4.4
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 4.39
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 4.39
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 4.38
6mer seed toxicity in tumour suppressive microRNAs 4.35
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 4.29
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 4.29
m6A-dependent regulation of messenger RNA stability 4.28
Cajal bodies are linked to genome conformation [RNA-Seq] 4.26
Cajal bodies are linked to genome conformation 4.26
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 4.2
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 4.18
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 4.18
Gene expression analysis of dengue-infected cells 4.1
Gene expression profile in breast cancer cells 4.07
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 4.07
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 4.04
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 4.0
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 3.98
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 3.96
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 3.96
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 3.93
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 3.92
Gene Expression Profiling of WT and KDM3A Knocked out Cell 3.92
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 3.92
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 3.85
Transcriptome of human ILC2s; primary vs IL-1b-primed 3.78
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 3.73
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 3.7
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 3.69
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 3.69
nELAVL HITS-CLIP in Alzheimer's Disease patients 3.65
Effect of BMP inhibition or stimulation of primary human keratinocytes 3.64
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 3.64
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.52
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 3.5
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 3.49
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.49
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 3.43
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 3.42
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 3.4
RNA-seq of MDA-MB-231 cells with TET1 knockout 3.39
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 3.38
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 3.31
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 3.3
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 3.3
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 3.3
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 3.26
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 3.22
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 3.2
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 3.2
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 3.19
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 3.15
The MEF2B Regulatory Network 3.1
The MEF2B Regulatory Network - RNA-seq data 3.1
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 3.03
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 3.03
Aneuploidy-induced cellular stresses limit autophagic degradation. 3.01
Global response to chemotherapy-induced apoptosis 2.94
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 2.94
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 2.93
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 2.92
Human Treg NaCl stimulation 2.88
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 2.88
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 2.88
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.86
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 2.85
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 2.85
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 2.83
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 2.82
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 2.79
UV_24h_GRO-Seq 2.78
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 2.77
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 2.77
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 2.77
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 2.7
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 2.69
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 2.66
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 2.6
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 2.59
CD73 knockdown effect in pancreatic cancer cell lines 2.58
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 2.57
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 2.51
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 2.51
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 2.5
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 2.49
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 2.48
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 2.46
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 2.43
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 2.42
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 2.41
Transcriptome analysis of SKI knock-out in HL60 cells 2.41
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.4
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.4
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 2.38
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 2.32
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 2.31
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.31
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 2.25
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 2.23
Functional significance of the HIV-1 Tat signature amino acid residues 2.18
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 2.17
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 2.16
Next generation sequencing of small RNAs isolated from exosomes in human semen 2.13
ARID1A and ARID1B loss in HCT116 cells 2.08
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 2.07
siRNA-mediated knockdown 2.03
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 2.03
Positively selected enhancer elements endow tumor cells with metastatic competence 2.02
RNA editing in nascent RNA affects pre-mRNA splicing 1.98
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 1.94
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 1.93
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 1.88
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.87
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 1.85
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 1.82
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.77
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 1.71
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 1.71
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 1.7
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 1.69
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 1.66
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 1.63
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 1.63
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.62
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 1.62
RNA sequencing of human mammary epithelial cells 1.57
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 1.56
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 1.56
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.53
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 1.53
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 1.52
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 1.52
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 1.52
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 1.5
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 1.47
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 1.45
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 1.41
Transposon-based construction of strand-specific RNA-seq libraries 1.33
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 1.33
Gene expression changes due to PARP knockdown in human cells 1.3
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 1.3
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.27
Myc activation coordinates gene transcription and protein translation responses 1.26
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.25
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 1.23
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 1.23
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.2
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 1.16
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 1.13
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 1.13
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.13
Small-molecule targeting of brachyury transcription factor addiction in chordoma 1.12
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 1.11
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 1.1
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.09
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.07
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.03
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.02
Measure transcript integrity using RNA-seq data 1.0
CHCHD2 gene KO effect in iPSC drived motor neurons 0.97
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.96
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.95
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.94
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.93
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.92
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.91
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.86
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.82
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.8
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.77
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.75
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.72
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.71
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.7
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 0.69
p53 activity results in DNA replication fork processivity 0.69
hNSCs siRNA NOVA2 0.69
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.67
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.67
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.64
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.64
Genome-wide analysis of the Integrator complex (HTS) 0.56
Genome-wide analysis of the Integrator complex 0.56
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.55
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.51
6mer seed toxicity in viral microRNAs 0.51
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.45
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.44
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.42
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 0.41
Global transcriptome analysis of WT versus HEB-/- hESCs 0.39
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.36
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.36
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.35
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 0.34
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.34
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.34
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.32
Loss of CREBBP results in gene expression repression in lymphoma cells 0.27
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.27
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 0.26
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.26
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 0.26
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 0.24
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.21
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 0.2
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.19
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.15
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.14
Function and hormonal regulation of GATA3 in human first trimester placentation 0.13
Modeling Human Cancer-induced Cachexia (Human) 0.13
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.12
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.1
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.07
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.06
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.03
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.03
RNA-seq data 0.03
The role of CFTR in islet function 0.0
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation